Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Allez

Showing results (71-80 of 205) with videos related to

Pageof 21
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 5, 2013
Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's diseaseJean-Frédéric Colombel, William J Sandborn, Matthieu Allez, et al.
Journal for Immunotherapy of Cancer|March 16, 2019
Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatmentTristan Courau, Julie Bonnereau, Justine Chicoteau, et al.
Gut|August 25, 2022
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab: when the remission state hides different types of residual disease activityNicolas Pierre, Vân Anh Huynh-Thu, Thomas Marichal, et al.
Alimentary Pharmacology & Therapeutics|June 2, 2026
The Association of Faecal Calprotectin Measurements With Endo-Histological Remission in Ulcerative Colitis: A Pooled AnalysisLaurie-Rose Dubé, Mark Sorin, Matthieu Allez, et al.
Clinics and Research in Hepatology and Gastroenterology|December 7, 2025
Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factorAurélien Amiot, Julien Kirchgesner, Hadrien Alric, et al.
Oncoimmunology|September 26, 2015
Phenotypic analysis of T cells infiltrating colon cancers: Correlations with oncogenetic statusMircea Chirica, Lionel Le Bourhis, Jacqueline Lehmann-Che, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 2, 2016
Diffusion-weighted MRI in Crohn's disease: Current status and recommendationsAnthony Dohan, Stuart Taylor, Christine Hoeffel, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 1, 2021
Chronic pouchitis and Crohn's disease of the pouch after ileal pouch-anal anastomosis: Incidence and risk factorsClément Bresteau, Aurélien Amiot, Julien Kirchgesner, et al.
Frontiers in Immunology|April 23, 2020
A Machine Learning Approach for High-Dimensional Time-to-Event Prediction With Application to Immunogenicity of Biotherapies in the ABIRISK CohortJulianne Duhazé, Signe Hässler, Delphine Bachelet, et al.
Nucleic Acids Research|December 17, 2025
DENetwork unveils non-differentially expressed genes with functional relevance across conditions through information flow perturbationBowen Zhao, Ting-Yi Su, Jingtao Wang, et al.
Pageof 21

Showing results (71-80 of 205) with videos related to

Sort By:
Pageof 21
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 5, 2013
Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's diseaseJean-Frédéric Colombel, William J Sandborn, Matthieu Allez, et al.
Journal for Immunotherapy of Cancer|March 16, 2019
Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatmentTristan Courau, Julie Bonnereau, Justine Chicoteau, et al.
Gut|August 25, 2022
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab: when the remission state hides different types of residual disease activityNicolas Pierre, Vân Anh Huynh-Thu, Thomas Marichal, et al.
Alimentary Pharmacology & Therapeutics|June 2, 2026
The Association of Faecal Calprotectin Measurements With Endo-Histological Remission in Ulcerative Colitis: A Pooled AnalysisLaurie-Rose Dubé, Mark Sorin, Matthieu Allez, et al.
Clinics and Research in Hepatology and Gastroenterology|December 7, 2025
Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factorAurélien Amiot, Julien Kirchgesner, Hadrien Alric, et al.
Oncoimmunology|September 26, 2015
Phenotypic analysis of T cells infiltrating colon cancers: Correlations with oncogenetic statusMircea Chirica, Lionel Le Bourhis, Jacqueline Lehmann-Che, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 2, 2016
Diffusion-weighted MRI in Crohn's disease: Current status and recommendationsAnthony Dohan, Stuart Taylor, Christine Hoeffel, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 1, 2021
Chronic pouchitis and Crohn's disease of the pouch after ileal pouch-anal anastomosis: Incidence and risk factorsClément Bresteau, Aurélien Amiot, Julien Kirchgesner, et al.
Frontiers in Immunology|April 23, 2020
A Machine Learning Approach for High-Dimensional Time-to-Event Prediction With Application to Immunogenicity of Biotherapies in the ABIRISK CohortJulianne Duhazé, Signe Hässler, Delphine Bachelet, et al.
Nucleic Acids Research|December 17, 2025
DENetwork unveils non-differentially expressed genes with functional relevance across conditions through information flow perturbationBowen Zhao, Ting-Yi Su, Jingtao Wang, et al.
Pageof 21